{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:26:30Z","timestamp":1761765990075},"reference-count":31,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.3892\/or.2016.4585","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T11:12:26Z","timestamp":1453374746000},"page":"2466-2472","source":"Crossref","is-referenced-by-count":20,"title":["Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells"],"prefix":"10.3892","volume":"35","author":[{"given":"RUITAO","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUIRONG","family":"SHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FANG","family":"REN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIA","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MINGHUI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEI","family":"FENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANYAN","family":"JIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"issue":"Suppl 7","key":"key20180107210805_b1-or-35-04-2466","doi-asserted-by":"crossref","first-page":"vii218","DOI":"10.1093\/annonc\/mdq377","article-title":"Optimal treatment for relapsing ovarian cancer","volume":"21","author":"Ledermann","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180107210805_b2-or-35-04-2466","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2010.06.003","article-title":"SGO White Paper on ovarian cancer: Etiology, screening and surveillance","volume":"119","author":"Schorge","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107210805_b3-or-35-04-2466","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"issue":"Suppl 7","key":"key20180107210805_b4-or-35-04-2466","doi-asserted-by":"crossref","first-page":"vii211","DOI":"10.1093\/annonc\/mdq368","article-title":"The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer","volume":"21","author":"Bookman","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180107210805_b5-or-35-04-2466","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20180107210805_b6-or-35-04-2466","first-page":"2689","article-title":"MACC1 as a marker for advanced colorectal carcinoma","volume":"30","author":"Shirahata","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180107210805_b7-or-35-04-2466","first-page":"3441","article-title":"MACC 1 as a marker for peritoneal-disseminated gastric carcinoma","volume":"30","author":"Shirahata","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180107210805_b8-or-35-04-2466","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jtcvs.2010.09.044","article-title":"Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence","volume":"141","author":"Shimokawa","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107210805_b9-or-35-04-2466","first-page":"777","article-title":"MACC 1 as a marker for vascular invasive hepatocellular carcinoma","volume":"31","author":"Shirahata","year":"2011","journal-title":"Anticancer Res"},{"key":"key20180107210805_b10-or-35-04-2466","first-page":"1551","article-title":"Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance","volume":"31","author":"Zhang","year":"2011","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20180107210805_b11-or-35-04-2466","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3892\/ol.2012.784","article-title":"MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance","volume":"4","author":"Wang","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180107210805_b12-or-35-04-2466","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7314\/APJCP.2015.16.1.195","article-title":"Influence of the MACC1 gene on sensitivity to chemotherapy in human U251 glioblastoma cells","volume":"16","author":"Shang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107210805_b13-or-35-04-2466","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1756-9966-30-83","article-title":"Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells","volume":"30","author":"Zhang","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107210805_b14-or-35-04-2466","first-page":"5225","article-title":"MicroRNA-133b targets glutathione S-transferase \u03c0 expression to increase ovarian cancer cell sensitivity to chemotherapy drugs","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"key20180107210805_b15-or-35-04-2466","first-page":"6687","article-title":"Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20180107210805_b16-or-35-04-2466","first-page":"651","article-title":"Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma","volume":"33","author":"Li","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180107210805_b17-or-35-04-2466","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/jop.12309","article-title":"The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma","volume":"44","author":"Li","year":"2015","journal-title":"J Oral Pathol Med"},{"key":"key20180107210805_b18-or-35-04-2466","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J"},{"key":"key20180107210805_b19-or-35-04-2466","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0889-8588(03)00056-X","article-title":"Oncogenic pathways implicated in ovarian epithelial cancer","volume":"17","author":"Nicosia","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107210805_b20-or-35-04-2466","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.bjc.6601048","article-title":"Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells","volume":"89","author":"Jin","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107210805_b21-or-35-04-2466","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2009.01.022","article-title":"Targeting the RAF-MEK-ERK pathway in cancer therapy","volume":"283","author":"Montagut","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107210805_b22-or-35-04-2466","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.febslet.2013.03.026","article-title":"Regulation of the MDR1 promoter by E2F1 and EAPP","volume":"587","author":"Andorfer","year":"2013","journal-title":"FEBS Lett"},{"key":"key20180107210805_b23-or-35-04-2466","doi-asserted-by":"crossref","first-page":"e98882","DOI":"10.1371\/journal.pone.0098882","article-title":"HIF-1\u03b1 inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1\/P-glycoprotein","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"key20180107210805_b24-or-35-04-2466","doi-asserted-by":"crossref","first-page":"e0125473","DOI":"10.1371\/journal.pone.0125473","article-title":"The effects and molecular mechanisms of miR-106a in multidrug resistance reversal in human glioma U87\/DDP and U251\/G cell lines","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"key20180107210805_b25-or-35-04-2466","doi-asserted-by":"crossref","first-page":"241763","DOI":"10.1155\/2013\/241763","article-title":"MDR gene expression analysis of six drug-resistant ovarian cancer cell lines","volume":"2013","author":"Januchowski","year":"2013","journal-title":"Biomed Res Int"},{"key":"key20180107210805_b26-or-35-04-2466","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ygyno.2005.01.027","article-title":"Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells","volume":"97","author":"Zhang","year":"2005","journal-title":"Gynecol Oncol"},{"key":"key20180107210805_b27-or-35-04-2466","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/14728222.2013.733001","article-title":"Targeting the Bcl-2 family for cancer therapy","volume":"17","author":"Thomas","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107210805_b28-or-35-04-2466","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1021\/mp500259e","article-title":"Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA\/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells","volume":"11","author":"Babu","year":"2014","journal-title":"Mol Pharm"},{"key":"key20180107210805_b29-or-35-04-2466","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jep.2013.04.023","article-title":"The anti-cancer activity of Antrodia camphorata against human ovarian carcinoma (SKOV-3) cells via modulation of HER-2\/neu signaling pathway","volume":"148","author":"Yang","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"key20180107210805_b30-or-35-04-2466","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/onc.2011.459","article-title":"Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"key20180107210805_b31-or-35-04-2466","first-page":"660","article-title":"Isochamaejasmin induces apoptosis in leukemia cells through inhibiting Bcl-2 family proteins","volume":"13","author":"Zhang","year":"2015","journal-title":"Chin J Nat Med"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4585\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T06:17:25Z","timestamp":1600064245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,1,21]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.3892\/or.2016.4585"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4585","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}